The challenge of this novel, he declared the newspaper 'The Wall Street Journal' a spokesman for the laboratory that has developed-Medical-Future, "was to get a stable vasodilator product (a gel Zanifil registered) not harm the rubber condom , considering that many can damage the latex with great ease. "

By using the condom, the penis comes into contact with the drug dose deposited at the end of the product. In this way, is to increase blood flow to the penis, which in principle leads to increased firmness of the member and a longer duration of the erection.

The results were evaluated in a study comparing the new with the traditional condom. According to the company, "the volunteers preferred the new condom. A significant percentage of men said that the 'blue condom" he reported greater erection and most of the women surveyed claimed that their sexual experience was more lasting. "

The British company expects that in less than a month the European Commission marketing authorization. The new condom is marketed by Reckitt Benckiser Group, responsible for the brand Durex. Their goal: to end men's excuses for not using condoms. Many complain that their erections are reduced and this pdoría be the solution.

Once it launches in Europe this device for the moment, is called CSD500, the company expects to obtain permission from the U.S.